US Patent Issued to BEAM THERAPEUTICS on April 14 for "Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence" (Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,971, issued on April 14, was assigned to BEAM THERAPEUTICS INC. (Cambridge, Mass.).

"Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence" was invented by Nicole Gaudelli (Cambridge, Mass.), Michael Packer (Cambridge, Mass.), Ian Slaymaker (Cambridge, Mass.), Yi Yu (Cambridge, Mass.), Bernd Zetsche (Cambridge, Mass.), David A. Born (Cambridge, Mass.), Seung-Joo Lee (Cambridge, Mass.) and Jason M. Gehrke (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features genetically modified immune cells comprising novel adenosine base editors (e.g., ABE8) having en...